Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by Freestone Capital Holdings LLC

Freestone Capital Holdings LLC cut its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 12.1% during the fourth quarter, HoldingsChannel reports. The fund owned 2,313 shares of the biotechnology company’s stock after selling 317 shares during the period. Freestone Capital Holdings LLC’s holdings in Axon Enterprise were worth $1,375,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Prestige Wealth Management Group LLC lifted its holdings in Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the last quarter. New Wave Wealth Advisors LLC acquired a new position in Axon Enterprise during the fourth quarter worth $40,000. Brooklyn Investment Group acquired a new position in Axon Enterprise during the third quarter worth $41,000. Y.D. More Investments Ltd acquired a new position in Axon Enterprise during the fourth quarter worth $45,000. Finally, Planning Capital Management Corp lifted its stake in Axon Enterprise by 83.3% during the third quarter. Planning Capital Management Corp now owns 121 shares of the biotechnology company’s stock worth $48,000 after purchasing an additional 55 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

AXON has been the topic of a number of research reports. Barclays set a $726.00 price target on Axon Enterprise and gave the stock an “overweight” rating in a research note on Thursday, February 27th. The Goldman Sachs Group upped their price target on Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Needham & Company LLC restated a “buy” rating and set a $600.00 price target on shares of Axon Enterprise in a research note on Wednesday, February 26th. Robert W. Baird upped their price target on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. Finally, Northland Securities increased their price objective on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research note on Monday, November 11th. Three equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $587.38.

Insiders Place Their Bets

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the firm’s stock in a transaction dated Monday, December 16th. The stock was sold at an average price of $639.69, for a total transaction of $639,690.00. Following the transaction, the director now owns 24,259 shares of the company’s stock, valued at approximately $15,518,239.71. This trade represents a 3.96 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 5,146 shares of company stock valued at $3,262,847. 6.10% of the stock is currently owned by insiders.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $499.31 on Friday. The firm has a market capitalization of $38.07 billion, a PE ratio of 129.02, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The business’s fifty day moving average price is $603.60 and its 200 day moving average price is $527.57. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.